OncoCyte Corporation (OCX)

OncoCyte Revenue

OncoCyte had revenue of $1.38M in the twelve months ending March 31, 2024, with 57.94% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $176.00K. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.

• Revenue (ttm): $1.38M
• Revenue Growth: +57.94%
• P/S Ratio: 31.04
• Revenue / Employee: $30,043
• Employees: 46
• Market Cap: 42.90M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.